A citation-based method for searching scientific literature

Alexia M Thomas, Nghiem Bui, Jennifer R Perkins, Lisa A Yuva-Paylor, Richard Paylor. Psychopharmacology (Berl) 2012
Times Cited: 69







List of co-cited articles
1237 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The mGluR theory of fragile X mental retardation.
Mark F Bear, Kimberly M Huber, Stephen T Warren. Trends Neurosci 2004
66

Correction of fragile X syndrome in mice.
Gül Dölen, Emily Osterweil, B S Shankaranarayana Rao, Gordon B Smith, Benjamin D Auerbach, Sumantra Chattarji, Mark F Bear. Neuron 2007
689
55

Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP.
Q J Yan, M Rammal, M Tranfaglia, R P Bauchwitz. Neuropharmacology 2005
392
52

Chronic pharmacological mGlu5 inhibition corrects fragile X in adult mice.
Aubin Michalon, Michael Sidorov, Theresa M Ballard, Laurence Ozmen, Will Spooren, Joseph G Wettstein, Georg Jaeschke, Mark F Bear, Lothar Lindemann. Neuron 2012
348
52

Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO mice.
Femke M S de Vrij, Josien Levenga, Herma C van der Linde, Sebastiaan K Koekkoek, Chris I De Zeeuw, David L Nelson, Ben A Oostra, Rob Willemsen. Neurobiol Dis 2008
239
49

Altered synaptic plasticity in a mouse model of fragile X mental retardation.
Kimberly M Huber, Sean M Gallagher, Stephen T Warren, Mark F Bear. Proc Natl Acad Sci U S A 2002
963
42

Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056.
Sébastien Jacquemont, Aurore Curie, Vincent des Portes, Maria Giulia Torrioli, Elizabeth Berry-Kravis, Randi J Hagerman, Feliciano J Ramos, Kim Cornish, Yunsheng He, Charles Paulding,[...]. Sci Transl Med 2011
256
36

Mutations causing syndromic autism define an axis of synaptic pathophysiology.
Benjamin D Auerbach, Emily K Osterweil, Mark F Bear. Nature 2011
419
34

Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome.
A J Verkerk, M Pieretti, J S Sutcliffe, Y H Fu, D P Kuhl, A Pizzuti, O Reiner, S Richards, M F Victoria, F P Zhang. Cell 1991
27

A pilot open label, single dose trial of fenobam in adults with fragile X syndrome.
E Berry-Kravis, D Hessl, S Coffey, C Hervey, A Schneider, J Yuhas, J Hutchison, M Snape, M Tranfaglia, D V Nguyen,[...]. J Med Genet 2009
265
27

FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism.
Jennifer C Darnell, Sarah J Van Driesche, Chaolin Zhang, Ka Ying Sharon Hung, Aldo Mele, Claire E Fraser, Elizabeth F Stone, Cynthia Chen, John J Fak, Sung Wook Chi,[...]. Cell 2011
26


Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism.
Jill L Silverman, Daniel G Smith, Stacey J Sukoff Rizzo, Michael N Karras, Sarah M Turner, Seda S Tolu, Dianne K Bryce, Deborah L Smith, Kari Fonseca, Robert H Ring,[...]. Sci Transl Med 2012
182
26

Genetic reduction of group 1 metabotropic glutamate receptors alters select behaviors in a mouse model for fragile X syndrome.
Alexia M Thomas, Nghiem Bui, Deanna Graham, Jennifer R Perkins, Lisa A Yuva-Paylor, Richard Paylor. Behav Brain Res 2011
55
30


Minocycline promotes dendritic spine maturation and improves behavioural performance in the fragile X mouse model.
T V Bilousova, L Dansie, M Ngo, J Aye, J R Charles, D W Ethell, I M Ethell. J Med Genet 2009
317
24

Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABAB receptors with arbaclofen.
Christina Henderson, Lasani Wijetunge, Mika Nakamoto Kinoshita, Matthew Shumway, Rebecca S Hammond, Friso R Postma, Christopher Brynczka, Roger Rush, Alexia Thomas, Richard Paylor,[...]. Sci Transl Med 2012
175
24

Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP.
Jill L Silverman, Seda S Tolu, Charlotte L Barkan, Jacqueline N Crawley. Neuropsychopharmacology 2010
281
23

Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome.
C M Spencer, O Alekseyenko, E Serysheva, L A Yuva-Paylor, R Paylor. Genes Brain Behav 2005
244
21

AFQ056, a new mGluR5 antagonist for treatment of fragile X syndrome.
Josien Levenga, Shigemi Hayashi, Femke M S de Vrij, Sebastiaan K Koekkoek, Herma C van der Linde, Ingeborg Nieuwenhuizen, Cheng Song, Ronald A M Buijsen, Andreea S Pop, Baltazar Gomezmancilla,[...]. Neurobiol Dis 2011
86
21


Dysregulation of mTOR signaling in fragile X syndrome.
Ali Sharma, Charles A Hoeffer, Yukihiro Takayasu, Takahiro Miyawaki, Sean M McBride, Eric Klann, R Suzanne Zukin. J Neurosci 2010
397
20

Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of fragile X syndrome.
Christopher J Yuskaitis, Marjelo A Mines, Margaret K King, J David Sweatt, Courtney A Miller, Richard S Jope. Biochem Pharmacol 2010
133
20

Early continuous inhibition of group 1 mGlu signaling partially rescues dendritic spine abnormalities in the Fmr1 knockout mouse model for fragile X syndrome.
Tao Su, Hong-Xing Fan, Tao Jiang, Wei-Wen Sun, Wei-Yi Den, Mei-Mei Gao, Sheng-Qiang Chen, Qi-Hua Zhao, Yong-Hong Yi. Psychopharmacology (Berl) 2011
50
28

Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors.
Mika Nakamoto, Vijayalaxmi Nalavadi, Michael P Epstein, Usha Narayanan, Gary J Bassell, Stephen T Warren. Proc Natl Acad Sci U S A 2007
177
20


Effects of STX209 (arbaclofen) on neurobehavioral function in children and adults with fragile X syndrome: a randomized, controlled, phase 2 trial.
Elizabeth M Berry-Kravis, David Hessl, Barbara Rathmell, Peter Zarevics, Maryann Cherubini, Karen Walton-Bowen, Yi Mu, Danh V Nguyen, Joseph Gonzalez-Heydrich, Paul P Wang,[...]. Sci Transl Med 2012
226
20

Rescue of dendritic spine phenotype in Fmr1 KO mice with the mGluR5 antagonist AFQ056/Mavoglurant.
Andreea S Pop, Josien Levenga, Celine E F de Esch, Ronald A M Buijsen, Ingeborg M Nieuwenhuizen, Tracy Li, Aaron Isaacs, Fabrizio Gasparini, Ben A Oostra, Rob Willemsen. Psychopharmacology (Berl) 2014
59
23

Alterations in the auditory startle response in Fmr1 targeted mutant mouse models of fragile X syndrome.
Darci M Nielsen, William J Derber, Danielle A McClellan, Linda S Crnic. Brain Res 2002
114
18

Modulation of behavioral phenotypes by a muscarinic M1 antagonist in a mouse model of fragile X syndrome.
Surabi Veeraragavan, Nghiem Bui, Jennie R Perkins, Lisa A Yuva-Paylor, Randall L Carpenter, Richard Paylor. Psychopharmacology (Berl) 2011
44
29

Cognitive dysfunction and prefrontal synaptic abnormalities in a mouse model of fragile X syndrome.
Dilja D Krueger, Emily K Osterweil, Stephanie P Chen, Lynne D Tye, Mark F Bear. Proc Natl Acad Sci U S A 2011
110
18

Modifying behavioral phenotypes in Fmr1KO mice: genetic background differences reveal autistic-like responses.
Corinne M Spencer, Olga Alekseyenko, Shannon M Hamilton, Alexia M Thomas, Ekaterina Serysheva, Lisa A Yuva-Paylor, Richard Paylor. Autism Res 2011
149
18

Chronic administration of AFQ056/Mavoglurant restores social behaviour in Fmr1 knockout mice.
Ilse Gantois, Andreea S Pop, Celine E F de Esch, Ronald A M Buijsen, Tine Pooters, Baltazar Gomez-Mancilla, Fabrizio Gasparini, Ben A Oostra, Rudi D'Hooge, Rob Willemsen. Behav Brain Res 2013
68
19


Behavioral and neuroanatomical characterization of the Fmr1 knockout mouse.
Yann S Mineur, Frans Sluyter, Sanne de Wit, Ben A Oostra, Wim E Crusio. Hippocampus 2002
152
17

The effect of an mGluR5 inhibitor on procedural memory and avoidance discrimination impairments in Fmr1 KO mice.
M F Vinueza Veloz, R A M Buijsen, R Willemsen, A Cupido, L W J Bosman, S K E Koekkoek, J W Potters, B A Oostra, C I De Zeeuw. Genes Brain Behav 2012
46
26


Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety.
Alexia Thomas, April Burant, Nghiem Bui, Deanna Graham, Lisa A Yuva-Paylor, Richard Paylor. Psychopharmacology (Berl) 2009
422
17


Sensorimotor gating abnormalities in young males with fragile X syndrome and Fmr1-knockout mice.
P W Frankland, Y Wang, B Rosner, T Shimizu, B W Balleine, E M Dykens, E M Ornitz, A J Silva. Mol Psychiatry 2004
202
15

Molecular mechanisms of fragile X syndrome: a twenty-year perspective.
Michael R Santoro, Steven M Bray, Stephen T Warren. Annu Rev Pathol 2012
352
15

Elevated glycogen synthase kinase-3 activity in Fragile X mice: key metabolic regulator with evidence for treatment potential.
Wenzhong William Min, Christopher J Yuskaitis, Qijiang Yan, Christopher Sikorski, Shengqiang Chen, Richard S Jope, Robert P Bauchwitz. Neuropharmacology 2009
100
15

Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination.
S A Irwin, B Patel, M Idupulapati, J B Harris, R A Crisostomo, B P Larsen, F Kooy, P J Willems, P Cras, P B Kozlowski,[...]. Am J Med Genet 2001
516
15

Minocycline treatment reverses ultrasonic vocalization production deficit in a mouse model of Fragile X Syndrome.
Sarah E Rotschafer, Michael S Trujillo, Lorraine E Dansie, Iryna M Ethell, Khaleel A Razak. Brain Res 2012
82
15


Genetic reduction of muscarinic M4 receptor modulates analgesic response and acoustic startle response in a mouse model of fragile X syndrome (FXS).
Surabi Veeraragavan, Deanna Graham, Nghiem Bui, Lisa A Yuva-Paylor, Jürgen Wess, Richard Paylor. Behav Brain Res 2012
35
31

A randomized double-blind, placebo-controlled trial of minocycline in children and adolescents with fragile x syndrome.
Mary Jacena S Leigh, Danh V Nguyen, Yi Mu, Tri I Winarni, Andrea Schneider, Tasleem Chechi, Jonathan Polussa, Paul Doucet, Flora Tassone, Susan M Rivera,[...]. J Dev Behav Pediatr 2013
155
15

Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by the small-molecule PAK inhibitor FRAX486.
Bridget M Dolan, Sergio G Duron, David A Campbell, Benedikt Vollrath, B S Shankaranarayana Rao, Hui-Yeon Ko, Gregory G Lin, Arvind Govindarajan, Se-Young Choi, Susumu Tonegawa. Proc Natl Acad Sci U S A 2013
143
15

Excess phosphoinositide 3-kinase subunit synthesis and activity as a novel therapeutic target in fragile X syndrome.
Christina Gross, Mika Nakamoto, Xiaodi Yao, Chi-Bun Chan, So Y Yim, Keqiang Ye, Stephen T Warren, Gary J Bassell. J Neurosci 2010
185
14



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.